A meta-analysis comparing the safety and efficacy of azithromycin over the alternate drugs used for treatment of uncomplicated enteric fever

Journal of Postgraduate Medicine

Volumn 58, Issue 2, 2012, Pages 112-118

  Trivedi, N A ^a   Shah, P C ^a  

^a Baroda Medical College   (India)

Author keywords

Azithromycin; ceftriaxone; chloramphenicol; enteric fever; fluoroquinolones

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; GATIFLOXACIN; NALIDIXIC ACID; OFLOXACIN; QUINOLONE DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTHROPATHY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CULTURE; CHILD; CONSTIPATION; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DRY THROAT; FECES CULTURE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; INJECTION SITE PAIN; JOINT DISCOMFORT; LIVER DYSFUNCTION; LOOSE FECES; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; META ANALYSIS (TOPIC); NAUSEA; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RELAPSE; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SIDE EFFECT; THROMBOCYTOSIS; TREATMENT DURATION; TYPHOID FEVER; VOMITING; XEROSTOMIA;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEPHALOSPORINS; CHLORAMPHENICOL; CONFIDENCE INTERVALS; FLUOROQUINOLONES; HUMANS; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SALMONELLA TYPHI; TREATMENT OUTCOME; TYPHOID FEVER;

EID: 84863667295     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.97172     Document Type: Article

References (19)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004;82:346-53.
2. Thaver D, Zaidi AK, Critchley J, Azmatullah A, Madni SA, Bhutta ZA. A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: Meta analysis. BMJ 2009;338:b1865.
3. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med 2002;347:1770-82.
4. Parry CM. The treatment of multidrug resistant and nalidixic acid resistant typhoid fever in Vietnam. Trans R Soc Trop Med Hyg 2004;98:413-22.
5. Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2008;4:CD006083.
6. Harish BN, Menezes GA. Antimicrobial resistance in typhoidal salmonellae. Indian J Med Microbiol 2011;29:223-9.
7. Vaudaux BP, Cherpillod J, Dayer P. Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients. J Antimicrob Chemother 1996;37 Suppl C:45-51.
8. Wildfeuer A, Laufen H, Zimmermann T. Distribution of orally administered azithromycin in various blood compartments. Int J Clin Pharmacol Ther 1994;32:356-60.
9. Wildfeuer A, Laufen H, Zimmermann T. Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob Agents Chemother 1996;40:75-9.
10. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
11. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: Comprehensive free software for meta analysis of causal research data. BMC Med Res Methodol 2006;6:50.
12. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systemic reviews and meta analysis: the PRISMA statement. BMJ 2009;339:b2535.
13. Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, Khakhria R, et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 1999;44:243-50.
14. Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug resistant or nalidixic acidresistant enteric fever. Antimicrob Agents Chemother 2000;44:1855-9.
15. Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, Phung QT, et al. A multi center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 2008; 3:e2188.
16. Frenck RW Jr, Nakhla I, Sultan Y, Bassily SB, Girgis YF, David J, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 2000;31:1134-8.
17. Frenck RW Jr, Mansour A, Nakhla I, Sultan Y, Putnam S, Wierzba T, et al. Short course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis 2004;38:951-7.
18. Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999;43:1441-4.
19. Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, Tung le T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin azithromycin combination for treatment of multidrug resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007;51:819-25.